Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial
β Scribed by Herbert Riechelmann; Markus Wiesneth; Peter Schauwecker; Peter Reinhardt; Silke Gronau; Anita Schmitt; Carsten Schroen; Judith Atz; Michael Schmitt
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 488 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Tumor metastasis to regional lymph nodes via the lymphatic system represents the first step of dissemination in head and neck squamous cell carcinoma (HNSCC) and serves as a major prognostic indicator for disease progression and as a guide for therapeutic strategies. In t
## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a singleβagent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som
## Abstract ## Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, singleβblinded clinical trial. ## Methods In all, 20 sub